<?xml version="1.0" encoding="UTF-8"?>
<p>Norfloxacin, tetracycline, ciprofloxacin, amoxicillin, kanamycin sulphate, nalidixic acid, streptomycin, novobiocin, gentamicin, amphotericin B, linoleic acid, dimethylsulfoxide, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT), trichloroacetic acid (TCA), acetic acid, Tris buffer, sulforhodamine B (SRB), RPMI-1640 medium (AutoModâ„¢), L-glutamine, glucose, bicarbonate of soda, and MOPS [3-(
 <italic>N</italic>-morpholino)propanesulfonic acid] buffer were purchased from Sigma-Aldrich (Poole, UK). Muller Hinton broth (MHB), Luria Bertani broth (LB), MacConkey agar, nutrient agar, Sabouraud dextrose agar, sodium chloride, sodium hydroxide, phosphate buffered saline (PBS) and human dermal fibroblasts, and adult (HDFa) cells were obtained from Fischer Scientific UK Ltd. Dulbecco's Modified Eagle's Medium (DMEM), Fetal Bovine Serum (FBS), and nonessential amino acids were obtained from Gibco. 
 <italic>Staphylococcus aureus</italic> XU212, which possesses the TetK tetracycline efflux pump and 
 <italic>mecA</italic> gene, was provided by Udo [
 <xref rid="B16" ref-type="bibr">16</xref>]. 
 <italic>S. aureus</italic> 1199B, which possesses the NorA efflux pump, was provided by Kaatz [
 <xref rid="B17" ref-type="bibr">17</xref>]. Dr. Paul Stapleton, UCL School of Pharmacy, provided all other bacterial and fungal strains used in this study.
</p>
